Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
It is FDA-approved for adults and pediatric patients aged 12 and older with obesity or overweight and at least one weight-related comorbidity.13 Liraglutide lowers blood sugar by enhancing insulin release and reducing appetite, with studies demonstrating a 15% reduction in caloric intake and an average weight loss of 18.5 lbs.10,14,15 While its mechanism of action is similar to semaglutide, liraglutide differs in dose, frequency, and formulation and should not be used interchangeably
Convenient Dosage Forms: Available in various strengths to suit your medical needs always administered by a healthcare professional for safety
"Often, it's something that may have a marginal pathway towards approval, or a really long time toward approval." The patient had been treated with tirzepatide Lilly's own dual-agonist obesity drug, sold as Zepbound, which the FDA approved in 2023 for approximately a year but achieved only moderate weight loss, according to sources familiar with the matter
Other Options May Be a Better Fit For People Who: Expect a satisfaction guarantee or want a risk-free trial
Counterfeiters are like any other businessman, says Geoffrey Potter, a US brand-protection attorney
US$ 26.22
US$ 27.38
US$ 25.43
US$ 21.76
US$ 23.55
US$ 26.41
